Genetic Testing Could Improve Treatment For Patients With The Virulent Multidrug-Resistant Fungus Candida Auris
Findings published in the special Clinical Chemistry issue, Genomics: Current & emerging trends in the clinical laboratory ...
LPOXY Therapeutics, Inc. Acquires Key Assets From Xeno Biosciences Inc. To Advance C. Difficile Prevention Therapy
"We are excited to advance Xeno's technology in a new therapeutic direction and to begin a pivotal Phase II study as we secure funding to support our clinical goals," said Larry Sutton, MD, PhD, ...